{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:42:30Z","timestamp":1780047750731,"version":"3.53.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.plefa.2020.102118","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T11:54:08Z","timestamp":1590062048000},"page":"102118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["THERAPEUTIC TARGETING OF BRAIN ARACHIDONIC ACID CASCADE IN BIPOLAR DISORDER BY LOW DOSE ASPIRIN AND CELECOXIB"],"prefix":"10.1016","volume":"159","author":[{"given":"Stanley I.","family":"Rapoport","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Hibbeln","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2020.102118_bib0001","series-title":"Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression","author":"Goodwin","year":"2007"},{"key":"10.1016\/j.plefa.2020.102118_bib0002","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pscychresns.2019.01.009","article-title":"Markers of neuroinflammation influence measures of cortical thickness in bipolar depression","volume":"285","author":"Poletti","year":"2019","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.1016\/j.plefa.2020.102118_bib0003","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2014.05.063","article-title":"The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited","volume":"753","author":"van Enkhuizen","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.plefa.2020.102118_bib0004","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biological psychiatry"},{"key":"10.1016\/j.plefa.2020.102118_bib0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/cn500058v","article-title":"Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade","volume":"5","author":"Rapoport","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.plefa.2020.102118_bib0006","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.mp.4001518","article-title":"Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers","volume":"9","author":"Gould","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.plefa.2020.102118_bib0007","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(96)13264-X","article-title":"Lithium decreases turnover of arachidonate in several brain phospholipids","volume":"220","author":"Chang","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.plefa.2020.102118_bib0008","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0165-0173(92)90016-F","article-title":"A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis","volume":"17","author":"Robinson","year":"1992","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.plefa.2020.102118_bib0009","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1471-4159.2001.00311.x","article-title":"Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers","volume":"77","author":"Chang","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.plefa.2020.102118_bib0010","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11064-005-2756-3","article-title":"Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat","volume":"30","author":"Lee","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1016\/j.plefa.2020.102118_bib0011","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1471-4159.2011.07410.x","article-title":"Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E(2) concentration in rat brain","volume":"119","author":"Cheon","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.plefa.2020.102118_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100858","article-title":"Coordination of gene expression of arachidonic and docosahexaenoic acid cascade enzymes during human brain development and aging","volume":"9","author":"Ryan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.plefa.2020.102118_bib0013","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.plefa.2020.102118_bib0014","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1096\/fasebj.9.8.7768353","article-title":"Muscarinic acetylcholine receptors: signal transduction through multiple effectors","volume":"9","author":"Felder","year":"1995","journal-title":"Faseb J"},{"key":"10.1016\/j.plefa.2020.102118_bib0015","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1194\/jlr.M006262","article-title":"Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid","volume":"51","author":"Ramadan","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plefa.2020.102118_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101223","article-title":"Neuroinflammation and neurodegeneration in adult rat brain from binge ethanol exposure: abrogation by docosahexaenoic acid","volume":"9","author":"Tajuddin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.plefa.2020.102118_bib0017","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01753889","article-title":"Differences in rates of incorporation of intravenously injected radiolabeled fatty acids into phospholipids of intracerebrally implanted tumor and brain in awake rats","volume":"12","author":"Nariai","year":"1994","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.plefa.2020.102118_bib0018","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1471-4159.2007.04558.x","article-title":"Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models","volume":"102","author":"Bosetti","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.plefa.2020.102118_bib0019","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.mp.4001111","article-title":"Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain","volume":"7","author":"Bosetti","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.plefa.2020.102118_bib0020","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/archpsyc.59.7.592","article-title":"Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?","volume":"59","author":"Rapoport","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.plefa.2020.102118_bib0021","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0002-9343(01)00834-8","article-title":"Antipyretics: mechanisms of action and clinical use in fever suppression","volume":"111","author":"Aronoff","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.plefa.2020.102118_bib0022","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.plefa.2015.01.002","article-title":"Low-dose aspirin (acetylsalicylate) prevents increases in brain PGE2, 15-epi-lipoxin A4 and 8-isoprostane concentrations in 9 month-old HIV-1 transgenic rats, a model for HIV-1 associated neurocognitive disorders","volume":"96","author":"Blanchard","year":"2015","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.plefa.2020.102118_bib0023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.plefa.2009.10.007","article-title":"Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder","volume":"82","author":"Stolk","year":"2010","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.plefa.2020.102118_bib0024","doi-asserted-by":"crossref","unstructured":"L.V. Kessing, H.C. Rytgaard, T.A. Gerds, M. Berk, C.T. Ekstrom, P.K. Andersen, New drug candidates for bipolar disorder-A nation-wide population-based study, Bipolar Disord, (2019).","DOI":"10.1111\/bdi.12772"},{"key":"10.1016\/j.plefa.2020.102118_bib0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-0035-1559667","article-title":"Effect of Adjunctive Celecoxib on BDNF in Manic Patients Undergoing Electroconvulsive Therapy: a Randomized Double Blind Controlled Trial","volume":"48","author":"Kargar","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.plefa.2020.102118_bib0026","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/bdi.12324","article-title":"Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial","volume":"17","author":"Arabzadeh","year":"2015","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.plefa.2020.102118_bib0027","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1089\/cap.2016.0207","article-title":"Double-Blind Placebo-Controlled Trial on Effectiveness and Safety of Celecoxib Adjunctive Therapy in Adolescents with Acute Bipolar Mania","volume":"27","author":"Mousavi","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.plefa.2020.102118_bib0028","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1871527317666181105162347","article-title":"Efficacy of Celecoxib Adjunct Treatment on Bipolar Disorder: Systematic Review and Meta-Analysis","volume":"18","author":"Bavaresco","year":"2019","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.plefa.2020.102118_bib0029","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000542-200502000-00026","article-title":"Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans","volume":"102","author":"Dembo","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.plefa.2020.102118_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0022-3999(95)00524-2","article-title":"Is aspirin, as used for antithrombosis, an emotion-modulating agent?","volume":"40","author":"Ketterer","year":"1996","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.plefa.2020.102118_bib0031","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bdi.12108","article-title":"Aspirin for treatment of lithium-associated sexual dysfunction in men: randomized double-blind placebo-controlled study","volume":"15","author":"Saroukhani","year":"2013","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.plefa.2020.102118_bib0032","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-017-0073-7","article-title":"Treatment of bipolar depression with minocycline and\/or aspirin: an adaptive, 2\u00d72 double-blind, randomized, placebo-controlled, phase IIA clinical trial","volume":"8","author":"Savitz","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.plefa.2020.102118_bib0033","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jad.2019.10.021","article-title":"Modulation of the inflammatory response benefits treatment-resistant bipolar depression: A randomized clinical trial","volume":"261","author":"Halaris","year":"2020","journal-title":"J Affect Disord"},{"key":"10.1016\/j.plefa.2020.102118_bib0034","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.912","article-title":"Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study","volume":"23","author":"Nery","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.plefa.2020.102118_bib0035","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/bdi.12742","article-title":"The need for prospective longitudinal cohort studies on the clinical staging models in bipolar disorder-A commentary to the study by van der Markt et\u00a0al, 2018","volume":"21","author":"Kessing","year":"2019","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.plefa.2020.102118_bib0036","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0006-8993(87)90352-0","article-title":"Evidence for increased activity of mouse brain fatty acid cyclooxygenase following drug-induced convulsions","volume":"408","author":"Lysz","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.plefa.2020.102118_bib0037","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41569-019-0225-y","article-title":"Role of aspirin in primary prevention of cardiovascular disease","volume":"16","author":"Patrono","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.plefa.2020.102118_bib0038","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/pds.4870","article-title":"Reduced risk of cancer among low-dose aspirin users: Data from French health care databases","volume":"28","author":"Ajrouche","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.plefa.2020.102118_bib0039","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.1804000116","article-title":"Aspirin-triggered proresolving mediators stimulate resolution in cancer","volume":"116","author":"Gilligan","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.plefa.2020.102118_bib0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.coph.2016.06.007","article-title":"Pharmacologic implications of inflammatory comorbidity in bipolar disorder","volume":"29","author":"Rosenblat","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.plefa.2020.102118_bib0041","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s100670050114","article-title":"Non-steroidal anti-inflammatory drugs with adverse psychiatric reactions: five case reports","volume":"18","author":"Jiang","year":"1999","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.plefa.2020.102118_bib0042","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41398-019-0570-y","article-title":"Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses","volume":"9","author":"Yuan","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.plefa.2020.102118_bib0043","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.3399\/bjgp14X677815","article-title":"High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study","volume":"64","author":"Koffeman","year":"2014","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.plefa.2020.102118_bib0044","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1046\/j.1471-4159.1995.64062765.x","article-title":"Dopamine D2 receptors potentiate arachidonate release via activation of cytosolic, arachidonate-specific phospholipase A2","volume":"64","author":"Vial","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.plefa.2020.102118_bib0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/mol.54.1.94","article-title":"Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus","volume":"54","author":"Berg","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.plefa.2020.102118_bib0046","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainresbull.2011.12.001","article-title":"Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans","volume":"87","author":"Basselin","year":"2012","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.plefa.2020.102118_bib0047","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/jcbfm.2011.171","article-title":"The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans","volume":"32","author":"Thambisetty","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.plefa.2020.102118_bib0048","doi-asserted-by":"crossref","DOI":"10.1002\/syn.22018","article-title":"[(11) C]arachidonic acid incorporation measurement in human brain: Optimization for clinical use","volume":"72","author":"Zanderigo","year":"2018","journal-title":"Synapse"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327820300764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327820300764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:08:19Z","timestamp":1760602099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327820300764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":48,"alternative-id":["S0952327820300764"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2020.102118","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"THERAPEUTIC TARGETING OF BRAIN ARACHIDONIC ACID CASCADE IN BIPOLAR DISORDER BY LOW DOSE ASPIRIN AND CELECOXIB","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2020.102118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102118"}}